Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

94 citing papers in PubMed, 210 citations in OpenAlex.

1. The CNNM-binding interface drives PRL-3-dependent tumor progression iniScience · 2026
   Article
2. Experimental models in immuno-oncology and their translational impact.Discover oncology · 2026
   Review
3. dUTPase is essential in zebrafish development and possesses several single-nucleotide variants with pronounced structural and functional consequences.FEBS open bio · 2026
   Article
4. Oxidative Stress, Genetic Factors and Behavioral Responses to Chemical Exposure: Insights into Cancer Development in Zebrafish (Danio Rerio).Biochemical genetics · 2026
   Review
5. Beyond the mouse: 3R-guided alternative animal models transforming cancer research.Molecular cancer · 2026
   Review
6. Choosing the right animal model for sarcoma research.Cellular and molecular life sciences : CMLS · 2026
   Review
7. Unraveling the therapeutic potential of Elaeagnus angustifolia extract on triple-negative breast cancer (TNBC): An investigation using zebrafish model.PloS one · 2026
   Article
8. Preclinical screening models in anticancer drug development: strengths, limitations, and translational challenges.Frontiers in pharmacology · 2026
   Review
9. Modelling the ageing dependence of cancer evolutionary trajectories.Nature reviews. Cancer · 2025
   Review
10. Choice of Animal Models to Investigate Cell Migration and Invasion in Glioblastoma.Cancers · 2025
    Review
11. Zebrafish in the spotlight: expanding Frontiers in toxicology and drug discovery.Toxicology research · 2025
    Review
12. Zebrafish as a Model for Translational Immuno-Oncology.Journal of personalized medicine · 2025
    Review
13. Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal from 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ-on-Chip, CRISPR Engineering, and AI-Driven Platforms-Challenges and Opportunities for Translational Precision Oncology.Cancers · 2025
    Review
14. Molecular Iodine Exhibited Differential Antiproliferative Actions in Progenitor and Stem Populations from Chemoresistant Cancer Cells.International journal of molecular sciences · 2025
    Article
15. Laboratory and physiological aspects of substitute metazoan models for in vivo pharmacotoxicological analysis.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
16. Zebrafish live imaging: a strong weapon in anticancer drug discovery and development.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
17. A zebrafish xenotransplant model of anaplastic thyroid cancer to study tumor microenvironment and innate immune cell interactions in vivo.Endocrine-related cancer · 2024
    Article
18. Histone Deacetylases in Retinoblastoma.International journal of molecular sciences · 2024
    Review
19. Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model.International journal of molecular sciences · 2024
    Review
20. Furan-based Chalcone Annihilates the Multi-Drug-Resistant Pseudomonas aeruginosa and Protects Zebra Fish Against its Infection.Journal of microbiology (Seoul, Korea) · 2024
    Article

34 more citing papers are in PubMed but not listed here.

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as